» Authors » Greg Hapgood

Greg Hapgood

Explore the profile of Greg Hapgood including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 30
Citations 512
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Erku D, Tobin J, Seymour J, MacManus M, Scuffham P, Hapgood G
EJHaem . 2025 Feb; 6(1):e70002. PMID: 39944796
Background: The TROG 99.03 trial demonstrated improved progression-free survival for patients with early-stage follicular lymphoma (FL) treated with systemic therapy using rituximab-cyclophosphamide, vincristine, prednisolone (R-CVP) after involved-field radiotherapy (RT) versus...
2.
Wang L, Chung E, Wellard C, Barraclough A, Campbell B, Chong G, et al.
Blood Adv . 2025 Jan; PMID: 39825862
Tumour 'bulk' has historically been considered an important prognostic marker and clinical tool to guide treatment in patients with lymphoma. However, its use and definitions in trial designs varies significantly...
3.
Hapgood G, Hill K, Okano S, Abro E, Looke D, Kennedy G, et al.
J Thromb Haemost . 2024 Nov; 23(2):627-634. PMID: 39549836
Background: Catheter-related thrombosis (CRT) is a complication of central venous access devices (CVADs). Evidence is variable regarding the significance of the side of catheter insertion. The role of the patient's...
4.
Barraclough A, Lee S, Villa D, Hapgood G, Wilson D, Chong G, et al.
Br J Haematol . 2024 Oct; 205(6):2254-2261. PMID: 39396827
Grade 3B follicular lymphoma (G3BFL) is a rare lymphoma thought to sit on a continuum between low-grade FL and diffuse large B-cell lymphoma (DLBCL). The prognostic impact of quantitative positron...
5.
Tobin J, Hapgood G, Johnston A, Cheah C, Lee S, Trotman J, et al.
Intern Med J . 2024 Aug; 54(8):1384-1395. PMID: 39099075
Follicular lymphoma (FL) is the most common indolent non-Hodgkin lymphoma subtype, accounting for 15-20% of all lymphoma diagnoses. Although typically slow-growing and responsive to frontline therapies, advanced-stage FL remains incurable...
6.
Hapgood G, Civallero M, Stepanishyna Y, Vose J, Cabrera M, Advani R, et al.
Blood Adv . 2023 May; 7(17):5047-5054. PMID: 37163360
The natural history of limited-stage peripheral T-cell lymphomas (PTCLs) remains poorly defined. We investigated outcomes and prognostic variables in patients registered in the T-Cell Project (TCP) (#NCT01142674) to develop a...
7.
Barraclough A, England J, Villa D, Wight J, Hapgood G, Conn J, et al.
Haematologica . 2023 Feb; 108(9):2444-2453. PMID: 36815381
Grade (G) 3B follicular lymphoma (FL) is a rare FL subtype which exists on a histological continuum between 'lowgrade' (Grade 1, 2 and 3A FL) and diffuse large B-cell lymphoma...
8.
Mistry V, Scott J, Wang T, Mollee P, Miles K, Law W, et al.
Cancer Imaging . 2023 Jan; 23(1):11. PMID: 36694244
Background: Accurate staging and response assessment are essential for prognosis and to guide treatment in patients with lymphoma. The aim of this study was to compare the diagnostic performance of...
9.
Yuan Y, Fuller R, Britton L, Birch S, Hapgood G, Cooper C
Intern Med J . 2022 Apr; 52(4):695-696. PMID: 35419968
No abstract available.
10.
Campbell A, Podbury B, Yue M, Mollee P, Bird R, Hapgood G
Hemasphere . 2021 Dec; 6(1):e674. PMID: 34938958
No abstract available.